Sio Capital Management as of Sept. 30, 2025
Portfolio Holdings for Sio Capital Management
Sio Capital Management holds 51 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Maximus (MMS) | 12.9 | $51M | 558k | 91.37 | |
| Celcuity (CELC) | 9.8 | $39M | 787k | 49.40 | |
| Sanofi Sa Sponsored Adr (SNY) | 6.7 | $27M | 563k | 47.20 | |
| Dianthus Therapeutics (DNTH) | 5.8 | $23M | 578k | 39.35 | |
| Alkermes SHS (ALKS) | 5.1 | $20M | 675k | 30.00 | |
| Disc Medicine (IRON) | 4.8 | $19M | 285k | 66.08 | |
| Merck & Co (MRK) | 3.8 | $15M | 177k | 83.93 | |
| Henry Schein (HSIC) | 3.7 | $15M | 219k | 66.37 | |
| Centene Corporation (CNC) | 3.5 | $14M | 388k | 35.68 | |
| Kenvue (KVUE) | 3.5 | $14M | 844k | 16.23 | |
| BioMarin Pharmaceutical (BMRN) | 3.1 | $12M | 225k | 54.16 | |
| GSK Sponsored Adr (GSK) | 2.9 | $12M | 269k | 43.16 | |
| Bright Minds Biosciences Com New (DRUG) | 2.9 | $12M | 191k | 60.66 | |
| Haemonetics Corporation (HAE) | 2.4 | $9.7M | 198k | 48.74 | |
| Aquestive Therapeutics (AQST) | 2.1 | $8.4M | 1.5M | 5.59 | |
| Kalvista Pharmaceuticals (KALV) | 2.1 | $8.3M | 684k | 12.18 | |
| Anteris Technologies Global (AVR) | 2.0 | $8.0M | 1.8M | 4.50 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.8 | $7.3M | 175k | 41.65 | |
| Tyra Biosciences (TYRA) | 1.8 | $7.2M | 515k | 13.99 | |
| Rapport Therapeutics (RAPP) | 1.4 | $5.5M | 185k | 29.70 | |
| Novocure Ord Shs (NVCR) | 1.4 | $5.3M | 414k | 12.92 | |
| Biosante Pharmaceuticals (ANIP) | 1.3 | $5.1M | 56k | 91.60 | |
| Edgewise Therapeutics (EWTX) | 1.3 | $5.0M | 307k | 16.22 | |
| Teleflex Incorporated (TFX) | 1.2 | $4.9M | 40k | 122.36 | |
| Simulations Plus (SLP) | 1.2 | $4.8M | 320k | 15.07 | |
| Proqr Therapeutics N V Shs Euro (PRQR) | 1.1 | $4.4M | 2.1M | 2.13 | |
| Shoulder Innovations Common Stock (SI) | 1.1 | $4.4M | 350k | 12.55 | |
| Pmv Pharmaceuticals (PMVP) | 0.9 | $3.7M | 2.6M | 1.40 | |
| Septerna (SEPN) | 0.9 | $3.6M | 189k | 18.81 | |
| Ideaya Biosciences (IDYA) | 0.9 | $3.4M | 124k | 27.21 | |
| Aligos Therapeutics Com New (ALGS) | 0.8 | $3.3M | 336k | 9.80 | |
| Erasca (ERAS) | 0.8 | $3.0M | 1.4M | 2.18 | |
| Vir Biotechnology (VIR) | 0.7 | $2.7M | 478k | 5.71 | |
| Savara (SVRA) | 0.7 | $2.6M | 727k | 3.57 | |
| Ventyx Biosciences (VTYX) | 0.7 | $2.6M | 829k | 3.11 | |
| Neuroone Med Technologies Com New (NMTC) | 0.5 | $2.1M | 2.4M | 0.89 | |
| Ovid Therapeutics (OVID) | 0.5 | $1.9M | 1.4M | 1.30 | |
| Bridgebio Oncology Therapeut Com New (BBOT) | 0.4 | $1.5M | 131k | 11.58 | |
| Context Therapeutics (CNTX) | 0.3 | $1.3M | 1.3M | 0.97 | |
| Senseonics Hldgs | 0.3 | $1.0M | 2.3M | 0.44 | |
| Tela Bio (TELA) | 0.2 | $948k | 636k | 1.49 | |
| Avalo Therapeutics Com New (AVTX) | 0.2 | $917k | 72k | 12.71 | |
| Foghorn Therapeutics (FHTX) | 0.2 | $601k | 123k | 4.89 | |
| Modular Med Com New (MODD) | 0.1 | $550k | 786k | 0.70 | |
| Nyxoah S A SHS (NYXH) | 0.1 | $234k | 51k | 4.60 | |
| Boundless Bio (BOLD) | 0.1 | $201k | 164k | 1.23 | |
| Aprea Therapeutics Com New (APRE) | 0.0 | $166k | 112k | 1.48 | |
| Terns Pharmaceuticals (TERN) | 0.0 | $76k | 10k | 7.51 | |
| Nextcure Com New (NXTC) | 0.0 | $64k | 11k | 5.86 | |
| Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $14k | 400k | 0.04 | |
| Humacyte *w Exp 08/27/202 (HUMAW) | 0.0 | $12k | 50k | 0.24 |
